Notice of Diabetes Mellitus Interagency Coordinating Committee Meeting, 64152-64153 [2020-22354]
Download as PDF
<![CDATA[
64152
Federal Register / Vol. 85, No. 197 / Friday, October 9, 2020 / Notices
Dated: October 5, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–22439 Filed 10–8–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Special Emphasis Panel,
November 12, 2020, 10:00 a.m. to
November 12, 2020, 5:00 p.m., National
Cancer Institute Shady Grove, Rockville,
MD 20850 which was published in the
Federal Register on September 04, 2020,
85 FR 55308.
This notice is being amended to
change the meeting start time from
10:00 a.m. to 1:00 p.m. The meeting will
now be held from 1:00 p.m. to 5:00 p.m.
on November 12, 2020. The meeting is
closed to the public.
Dated: October 5, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–22437 Filed 10–8–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Integrative Health; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Integrative Health
Special Emphasis Panel; Early Phase Clinical
Trials of Natural Products (NP).
Date: November 6, 2020.
VerDate Sep<11>2014
17:26 Oct 08, 2020
Jkt 253001
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: NIH, Democracy II, 6707 Democracy
Blvd., Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Martina Schmidt, Ph.D.,
Chief, Office of Scientific Review, National
Center for Complementary & Integrative
Health, NIH, 6707 Democracy Blvd., Suite
401, Bethesda, MD 20892, 301–594–3456,
schmidma@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: October 6, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–22438 Filed 10–8–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing; Correction
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice; correction.
The Department of Health and
Human Services, National Institutes of
Health published a Notice in the
Federal Register on October 1, 2020.
That Notice requires a correction in the
SUPPLEMENTARY INFORMATION section.
FOR FURTHER INFORMATION CONTACT:
Amy F. Petrik, Ph.D., licensing contact,
240–627–3721; amy.petrik@nih.gov.
Licensing information and copies of the
U.S. patent application may be obtained
by communicating with the licensing
contact at the Technology Transfer and
Intellectual Property Office, National
Institute of Allergy and Infectious
Diseases, 5601 Fishers Lane, Rockville,
MD 20852; tel. 301–496–2644. A signed
Confidential Disclosure Agreement will
be required to receive copies of
unpublished patent applications.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Correction
In the Federal Register of October 1,
2020, in FR Doc. 2020–21708, on page
61961, as found within the
SUPPLEMENTARY INFORMATION section.
The title of the invention, currently
reads ‘‘Structure-Based Design of
SARS2–CoV–2 Spike Immunogens
Stabilized in the RBD-All Down
Conformation’’ and should read
‘‘Structure-Based Design of SARS–CoV–
2 Spike Immunogens Stabilized in the
RBD-All Down Conformation’’.
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
Dated: October 5, 2020.
Daniel R Hernandez,
Federal Register Officer, National Institutes
of Health.
[FR Doc. 2020–22370 Filed 10–8–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of Diabetes Mellitus Interagency
Coordinating Committee Meeting
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The Diabetes Mellitus
Interagency Coordinating Committee
(DMICC) will hold a meeting on October
30, 2020. The topic for this meeting will
be ‘‘Health Literacy and Numeracy:
Considerations for Equity Approaches.’’
The meeting is open to the public.
DATES: The meeting will be held on
October 30, 2020 from 1 p.m. to 5:00
p.m. EDT.
ADDRESSES: The meeting will be held
via the online video conferencing—
Zoom. For details, and to register, please
contact dmicc@mail.nih.gov.
FOR FURTHER INFORMATION CONTACT: For
further information concerning this
meeting, including a draft agenda, see
the DMICC website,
www.diabetescommittee.gov, or contact
Dr. B. Tibor Roberts, Executive
Secretary of the Diabetes Mellitus
Interagency Coordinating Committee,
National Institute of Diabetes and
Digestive and Kidney Diseases, 31
Center Drive, Building 31A, Room
9A19, MSC 2560, Bethesda, MD 20892–
2560, telephone: 301–496–6623; FAX:
301–480–6741; email: dmicc@
mail.nih.gov.
SUPPLEMENTARY INFORMATION: In
accordance with 42 U.S. Code § 285c–3,
the DMICC, chaired by the National
Institute of Diabetes and Digestive and
Kidney Diseases (NIDDK) comprising
members of the Department of Health
and Human Services and other federal
agencies that support diabetes-related
activities, facilitates cooperation,
communication, and collaboration on
diabetes among government entities.
DMICC meetings, held several times a
year, provide an opportunity for
Committee members to learn about and
discuss current and future diabetes
programs in DMICC member
organizations and to identify
opportunities for collaboration. The
October 30, 2020 DMICC meeting will
focus on ‘‘Health Literacy and
SUMMARY:
E:\FR\FM\09OCN1.SGM
09OCN1
64153
Federal Register / Vol. 85, No. 197 / Friday, October 9, 2020 / Notices
Numeracy: Considerations for Equity
Approaches.’’
Any member of the public interested
in presenting oral comments to the
Committee should notify the contact
person listed on this notice at least 5
days in advance of the meeting.
Interested individuals and
representatives or organizations should
submit a letter of intent, a brief
description of the organization
represented, and a written copy of their
oral presentation in advance of the
meeting. Only one representative of an
organization will be allowed to present;
oral comments and presentations will be
limited to a maximum of 5 minutes.
Printed and electronic copies are
requested for the record. In addition,
any interested person may file written
comments with the Committee by
forwarding their statement to the
contact person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Because of time constraints for the
meeting, oral comments will be allowed
on a first-come, first-serve basis.
Members of the public who would
like to receive email notification about
future DMICC meetings should register
for the listserv available on the DMICC
website, www.diabetescommittee.gov.
Dated: October 5, 2020.
Bruce Tibor Roberts,
Executive Secretary, DMICC, Office of
Scientific Program and Policy Analysis,
National Institute of Diabetes and Digestive
and Kidney Diseases, National Institutes of
Health.
[FR Doc. 2020–22354 Filed 10–8–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Customs and Border Protection
Quarterly IRS Interest Rates Used in
Calculating Interest on Overdue
Accounts and Refunds on Customs
Duties
U.S. Customs and Border
Protection, Department of Homeland
Security.
ACTION: General notice.
AGENCY:
This notice advises the public
that the quarterly Internal Revenue
Service interest rates used to calculate
interest on overdue accounts
(underpayments) and refunds
(overpayments) of customs duties will
remain the same from the previous
quarter. For the calendar quarter
beginning October 1, 2020, the interest
rates for overpayments will be 2 percent
for corporations and 3 percent for noncorporations, and the interest rate for
underpayments will be 3 percent for
both corporations and non-corporations.
This notice is published for the
convenience of the importing public
and U.S. Customs and Border Protection
personnel.
DATES: The rates announced in this
notice are applicable as of October 1,
2020.
FOR FURTHER INFORMATION CONTACT:
Bruce Ingalls, Revenue Division,
Collection Refunds & Analysis Branch,
6650 Telecom Drive, Suite #100,
Indianapolis, Indiana 46278; telephone
(317) 298–1107.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Background
Pursuant to 19 U.S.C. 1505 and
Treasury Decision 85–93, published in
the Federal Register on May 29, 1985
(50 FR 21832), the interest rate paid on
applicable overpayments or
underpayments of customs duties must
Beginning date
070174
070175
020176
020178
020180
020182
010183
070183
010185
070185
010186
070186
010187
100187
VerDate Sep<11>2014
17:26 Oct 08, 2020
Underpayments
(percent)
Ending date
..........................................................
..........................................................
..........................................................
..........................................................
..........................................................
..........................................................
..........................................................
..........................................................
..........................................................
..........................................................
..........................................................
..........................................................
..........................................................
..........................................................
Jkt 253001
063075
013176
013178
013180
013182
123182
063083
123184
063085
123185
063086
123186
093087
123187
PO 00000
be in accordance with the Internal
Revenue Code rate established under 26
U.S.C. 6621 and 6622. Section 6621
provides different interest rates
applicable to overpayments: One for
corporations and one for noncorporations.
The interest rates are based on the
Federal short-term rate and determined
by the Internal Revenue Service (IRS) on
behalf of the Secretary of the Treasury
on a quarterly basis. The rates effective
for a quarter are determined during the
first-month period of the previous
quarter.
In Revenue Ruling 2020–18, the IRS
determined the rates of interest for the
calendar quarter beginning October 1,
2020, and ending on December 31, 2020.
The interest rate paid to the Treasury for
underpayments will be the Federal
short-term rate (0%) plus three
percentage points (3%) for a total of
three percent (3%) for both corporations
and non-corporations. For corporate
overpayments, the rate is the Federal
short-term rate (0%) plus two
percentage points (2%) for a total of two
percent (2%). For overpayments made
by non-corporations, the rate is the
Federal short-term rate (0%) plus three
percentage points (3%) for a total of
three percent (3%). These interest rates
used to calculate interest on overdue
accounts (underpayments) and refunds
(overpayments) of customs duties
remain the same from the previous
quarter. These interest rates are subject
to change for the calendar quarter
beginning January 1, 2021, and ending
on March 31, 2021.
For the convenience of the importing
public and U.S. Customs and Border
Protection personnel, the following list
of IRS interest rates used, covering the
period from July of 1974 to date, to
calculate interest on overdue accounts
and refunds of customs duties, is
published in summary format.
..........................................................
..........................................................
..........................................................
..........................................................
..........................................................
..........................................................
..........................................................
..........................................................
..........................................................
..........................................................
..........................................................
..........................................................
..........................................................
..........................................................
Frm 00046
Fmt 4703
Sfmt 4703
E:\FR\FM\09OCN1.SGM
6
9
7
6
12
20
16
11
13
11
10
9
9
10
09OCN1
Overpayments
(percent)
Corporate
overpayments
(eff. 1–1–99)
(percent)
6
9
7
6
12
20
16
11
13
11
10
9
8
9
........................
........................
........................
........................
........................
........................
........................
........................
........................
........................
........................
........................
........................
........................
]]>Agencies
[Federal Register Volume 85, Number 197 (Friday, October 9, 2020)]
[Notices]
[Pages 64152-64153]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-22354]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Notice of Diabetes Mellitus Interagency Coordinating Committee
Meeting
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Diabetes Mellitus Interagency Coordinating Committee
(DMICC) will hold a meeting on October 30, 2020. The topic for this
meeting will be ``Health Literacy and Numeracy: Considerations for
Equity Approaches.'' The meeting is open to the public.
DATES: The meeting will be held on October 30, 2020 from 1 p.m. to 5:00
p.m. EDT.
ADDRESSES: The meeting will be held via the online video conferencing--
Zoom. For details, and to register, please contact [email protected].
FOR FURTHER INFORMATION CONTACT: For further information concerning
this meeting, including a draft agenda, see the DMICC website,
www.diabetescommittee.gov, or contact Dr. B. Tibor Roberts, Executive
Secretary of the Diabetes Mellitus Interagency Coordinating Committee,
National Institute of Diabetes and Digestive and Kidney Diseases, 31
Center Drive, Building 31A, Room 9A19, MSC 2560, Bethesda, MD 20892-
2560, telephone: 301-496-6623; FAX: 301-480-6741; email:
[email protected].
SUPPLEMENTARY INFORMATION: In accordance with 42 U.S. Code Sec. 285c-
3, the DMICC, chaired by the National Institute of Diabetes and
Digestive and Kidney Diseases (NIDDK) comprising members of the
Department of Health and Human Services and other federal agencies that
support diabetes-related activities, facilitates cooperation,
communication, and collaboration on diabetes among government entities.
DMICC meetings, held several times a year, provide an opportunity for
Committee members to learn about and discuss current and future
diabetes programs in DMICC member organizations and to identify
opportunities for collaboration. The October 30, 2020 DMICC meeting
will focus on ``Health Literacy and
[[Page 64153]]
Numeracy: Considerations for Equity Approaches.''
Any member of the public interested in presenting oral comments to
the Committee should notify the contact person listed on this notice at
least 5 days in advance of the meeting. Interested individuals and
representatives or organizations should submit a letter of intent, a
brief description of the organization represented, and a written copy
of their oral presentation in advance of the meeting. Only one
representative of an organization will be allowed to present; oral
comments and presentations will be limited to a maximum of 5 minutes.
Printed and electronic copies are requested for the record. In
addition, any interested person may file written comments with the
Committee by forwarding their statement to the contact person listed on
this notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person. Because of time constraints for the meeting,
oral comments will be allowed on a first-come, first-serve basis.
Members of the public who would like to receive email notification
about future DMICC meetings should register for the listserv available
on the DMICC website, www.diabetescommittee.gov.
Dated: October 5, 2020.
Bruce Tibor Roberts,
Executive Secretary, DMICC, Office of Scientific Program and Policy
Analysis, National Institute of Diabetes and Digestive and Kidney
Diseases, National Institutes of Health.
[FR Doc. 2020-22354 Filed 10-8-20; 8:45 am]
BILLING CODE 4140-01-P
